Register entry
- Registered sites
- 0
- Active NDC listings
- 44
- Labeller names
- 2
- Live patents
- 51
- Countries
- 0
Catalogue
Drug listings by form and route
4444 active NDC listings: 44 human prescription drug. By marketing category: ANDA 31, NDA 7, NDA AUTHORIZED GENERIC 3, UNAPPROVED DRUG OTHER 3.
| Dosage form | NDCs |
|---|---|
| tablet | 16 |
| tablet, film coated | 6 |
| tablet, orally disintegrating | 6 |
| capsule | 4 |
| solution | 4 |
| tablet, extended release | 4 |
| granule, delayed release | 1 |
| solution/ drops | 1 |
| tablet, film coated, extended release | 1 |
| tincture | 1 |
| Route | NDCs |
|---|---|
| oral | 37 |
| sublingual | 6 |
| ophthalmic | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| edenbridge pharmaceuticals llc. | 43 |
| edenbridge pharmaceuticals, llc | 1 |
Exclusivity
Patents and exclusivities
51| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 8658198 | ZUBSOLVbuprenorphine hydrochloride; naloxone hydrochloride | product | Dec 2027 |
| 8470361 | ZUBSOLVbuprenorphine hydrochloride; naloxone hydrochloride | product | May 2030 |
| 10874661 | ZUBSOLVbuprenorphine hydrochloride; naloxone hydrochloride | product | Sept 2032 |
| 10946010 | ZUBSOLVbuprenorphine hydrochloride; naloxone hydrochloride | product | Sept 2032 |
| 11020387 | ZUBSOLVbuprenorphine hydrochloride; naloxone hydrochloride | product | Sept 2032 |
| 11020388 | ZUBSOLVbuprenorphine hydrochloride; naloxone hydrochloride | product | Sept 2032 |
| 11433066 | ZUBSOLVbuprenorphine hydrochloride; naloxone hydrochloride | use | Sept 2032 |
| 8940330 | ZUBSOLVbuprenorphine hydrochloride; naloxone hydrochloride | product | Sept 2032 |
| 9259421 | ZUBSOLVbuprenorphine hydrochloride; naloxone hydrochloride | product | Sept 2032 |
| 9439900 | ZUBSOLVbuprenorphine hydrochloride; naloxone hydrochloride | product | Sept 2032 |
Catalogue
Marketed products
44| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Albendazole | Albendazole | tablet, oral | 42799-110ANDA |
| Atropine sulfate | Atropine sulfate | solution/ drops, ophthalmic | 42799-826ANDA |
| Bisoprolol Fumarate and Hydrochlorothiazide | Bisoprolol Fumarate and Hydrochlorothiazide | tablet, film coated, oral | 42799-920ANDA |
| Bisoprolol Fumarate and Hydrochlorothiazide | Bisoprolol Fumarate and Hydrochlorothiazide | tablet, film coated, oral | 42799-921ANDA |
| Bisoprolol Fumarate and Hydrochlorothiazide | Bisoprolol Fumarate and Hydrochlorothiazide | tablet, film coated, oral | 42799-922ANDA |
| Bumetanide | Bumetanide | tablet, oral | 42799-119NDA AUTHORIZED GENERIC |
| Bumetanide | Bumetanide | tablet, oral | 42799-120NDA AUTHORIZED GENERIC |
| Bumetanide | Bumetanide | tablet, oral | 42799-121NDA AUTHORIZED GENERIC |
| Carbidopa | Carbidopa | tablet, oral | 42799-123ANDA |
| Colestipol Hydrochloride | Colestipol Hydrochloride | tablet, oral | 42799-115ANDA |
| Diclofenac Sodium | Diclofenac Sodium | tablet, extended release, oral | 42799-953ANDA |
| Donepezil hydrochloride | Donepezil hydrochloride | tablet, film coated, oral | 42799-954ANDA |
| Ethacrynic Acid | Ethacrynic Acid | tablet, oral | 42799-405ANDA |
| Etodolac | Etodolac | tablet, film coated, oral | 42799-111ANDA |
| Etodolac | Etodolac | tablet, film coated, oral | 42799-112ANDA |
| Hemady | dexamethasone | tablet, oral | 82111-955NDA |
| Isosorbide Mononitrate | Isosorbide Mononitrate | tablet, extended release, oral | 42799-958ANDA |
| Isosorbide Mononitrate | Isosorbide Mononitrate | tablet, extended release, oral | 42799-959ANDA |
| Isosorbide Mononitrate | Isosorbide Mononitrate | tablet, extended release, oral | 42799-960ANDA |
| Ivermectin | Ivermectin | tablet, oral | 42799-806ANDA |
| Loperamide Hydrochloride | Loperamide Hydrochloride | capsule, oral | 42799-605ANDA |
| Methenamine Mandelate | Methenamine Mandelate | tablet, oral | 42799-105UNAPPROVED DRUG OTHER |
| Methenamine Mandelate | Methenamine Mandelate | tablet, oral | 42799-106UNAPPROVED DRUG OTHER |
| Nintedanib | nintedanib | capsule, oral | 42799-972ANDA |
| Nintedanib | nintedanib | capsule, oral | 42799-973ANDA |
| Opium Tincture Deodorized | Morphine | tincture, oral | 42799-217UNAPPROVED DRUG OTHER |
| Pantoprazole Sodium | Pantoprazole Sodium | granule, delayed release, oral | 42799-952ANDA |
| Prednisolone Sodium Phosphate | Prednisolone Sodium Phosphate | solution, oral | 42799-812ANDA |
| Prednisolone Sodium Phosphate | Prednisolone Sodium Phosphate | solution, oral | 42799-813ANDA |
| Prednisolone Sodium Phosphate | Prednisolone Sodium Phosphate | solution, oral | 42799-815ANDA |
| Prednisolone Sodium Phosphate | Prednisolone Sodium Phosphate | solution, oral | 42799-816ANDA |
| Tinidazole | Tinidazole | tablet, oral | 42799-207ANDA |
| Tinidazole | Tinidazole | tablet, oral | 42799-208ANDA |
| Tofacitinib | Tofacitinib | tablet, film coated, extended release, oral | 42799-970ANDA |
| Vigabatrin | Vigabatrin | tablet, oral | 42799-950ANDA |
| Yargesa | Miglustat | capsule, oral | 42799-709ANDA |
| Zubsolv | buprenorphine hydrochloride and naloxone hydrochloride | tablet, orally disintegrating, sublingual | 82111-201NDA |
| Zubsolv | buprenorphine hydrochloride and naloxone hydrochloride | tablet, orally disintegrating, sublingual | 82111-202NDA |
| Zubsolv | buprenorphine hydrochloride and naloxone hydrochloride | tablet, orally disintegrating, sublingual | 82111-203NDA |
| Zubsolv | buprenorphine hydrochloride and naloxone hydrochloride | tablet, orally disintegrating, sublingual | 82111-204NDA |
| Zubsolv | buprenorphine hydrochloride and naloxone hydrochloride | tablet, orally disintegrating, sublingual | 82111-205NDA |
| Zubsolv | buprenorphine hydrochloride and naloxone hydrochloride | tablet, orally disintegrating, sublingual | 82111-206NDA |
| venlafaxine hydrochloride, extended release | venlafaxine hydrochloride, extended release | tablet, oral | 42799-962ANDA |
| venlafaxine hydrochloride, extended release | venlafaxine hydrochloride, extended release | tablet, oral | 42799-963ANDA |
Compare
Other companies listing buprenorphine hydrochloride and naloxone hydrochloride
- PAI Holdings, LLC1 site · 146 NDC
- Orexo US, Inc.0 sites · 6 NDC
Enquiry
Common questions
- Is Edenbridge Pharmaceuticals LLC. FDA approved?
- Edenbridge Pharmaceuticals LLC. holds no registered establishment of its own; 44 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Edenbridge Pharmaceuticals LLC. make?
- 44 products are listed under Edenbridge Pharmaceuticals LLC. in the openFDA NDC Directory, most often as tablet; tablet, film coated; tablet, orally disintegrating. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.